CBRCULi002-A

19-1035-10

General

Cell Line

hPSCreg name CBRCULi002-A
Cite as:
CBRCULi002-A (RRID:CVCL_C9IQ)
Alternative name(s)
19-1035-10
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
CBRCULi007-A
(14-0730-1)
Donor diseases:
myotonic dystrophy type 1
CBRCULi004-A
(79-1660-2)
Donor diseases:
myotonic dystrophy type 1
CBRCULi005-A
(91-3158-1)
Donor diseases:
myotonic dystrophy type 1
CHUQi001-A
(522-2666-2, SAMEA104271492)
Donor diseases:
myotonic dystrophy type 1
CBRCULi003-A
(59-0944-2)
Donor diseases:
myotonic dystrophy type 1
CBRCULi018-A
(91-2032-7)
Donor diseases:
myotonic dystrophy type 1
CBRCULi019-A
(19-1741-2)
Donor diseases:
myotonic dystrophy type 1
CBRCULi020-A
(79-1761-15)
Donor diseases:
myotonic dystrophy type 1
CBRCULi015-A
(GM23375-1, GM23375 clone 1)
Donor's gene variants:
DMPK – DM1 protein kinase, DMPK – DM1 protein kinase
Donor diseases:
Congenital Myotonic Dystrophy
ZZUi015-A
(ZZU-iPS-DM1-002)
Donor diseases:
myotonic dystrophy type 1
ZZUi006-A
(ZZU-iPS-DM1-001)
Donor's gene variants:
DMPK
Donor diseases:
Steinert myotonic dystrophy
RGIe057-A
(SI-148)
Donor diseases:
myotonic dystrophy type 1
HADe006-A
(HAD 6)
Donor diseases:
myotonic dystrophy type 1
CENSOi008-A
(FB77R2c3, CENSOi260)
Donor's gene variants:
DMPK, DMPK
Donor diseases:
myotonic dystrophy type 1
RGIe061-A
(SI-153)
Donor diseases:
myotonic dystrophy type 1
CBRCULi012-A
(GM04601 clone 21, GM04601-21)
Donor diseases:
myotonic dystrophy type 1
CBRCULi013-A
(GM04602-2, GM04602 clone 2)
Donor diseases:
myotonic dystrophy type 1
VUBe003-A
(VUB03_DM1)
Donor diseases:
myotonic dystrophy type 1
KCLe014-A
(KCL018_MD1)
Donor diseases:
myotonic dystrophy type 1
VUBe019-A
(VUB19_DM1)
Donor diseases:
Steinert myotonic dystrophy
HADe001-A
(HAD 1)
Donor diseases:
myotonic dystrophy type 1
Last update 25th January 2023
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator CERVO Brain Research Centre-Université Laval (CBRCUL)

External Databases

BioSamples SAMEA112366214
Cellosaurus CVCL_C9IQ
Wikidata Q123030860

General Information

Publications
* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: not allowed

Donor Information

General Donor Information

Sex male

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
The donor is a carrier of a disease-associated mutation and affected.
Synonyms
  • Dystrophia myotonica
  • Steinert disease
  • congenital myotonic dystrophy
  • myotonic dystrophy of Steinert
show more synonyms

External Databases (Donor)

BioSamples SAMEA112366215

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? No
Can you provide us with a copy of the Donor Information Sheet provided to the donor? Yes
Do you (Depositor/Provider) hold the original Donor Consent Form? Yes
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. anonymised
Does consent explicitly allow the derivation of pluripotent stem cells? No
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
How may genetic information associated with the cell line be accessed? No information
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? CHUQ Ethical Committee
Approval number A12-08-1022
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

Source cell type
Human cell line from tissue infected with Epstein-Barr virus, resembling a lymphoblast.
Synonyms
  • lymphoblastoid cell
Source cell origin
A liquid tissue; its major function is to transport oxygen throughout the body. It also supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. Several hormones also travel in the blood.
Synonyms
  • Reticuloendothelial System, Blood
  • Peripheral Blood
  • peripheral blood
  • blood
  • Blood
  • Whole Blood
  • BLOOD
  • portion of blood
  • vertebrate blood
show more synonyms

Reprogramming method

Vector type Non-integrating
Vector Sendai virus
Genes
Is reprogramming vector detectable?
No
Methods used
RT-PCR
Files and images showing reprogramming vector expressed or silenced

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Medium mTeSR™ Plus

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
NANOG
Yes
POU5F1 (OCT-4)
Yes
SOX2
Yes
TRA 1-60
Yes
SSEA-4
Yes
TRA 1-81
Yes
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro spontaneous differentiation
Scorecard
Marker Expressed
AFP
Yes
KLF5
Yes
SOX17
Yes
Mesoderm
Ont Id: UBERON_0000926
In vitro spontaneous differentiation
Scorecard
Marker Expressed
BMP10
Yes
ESM1
Yes
FOXF1
Yes
Ectoderm
Ont Id: UBERON_0000924
In vitro spontaneous differentiation
Scorecard
Marker Expressed
NR2F2
Yes
SDC2
Yes

Microbiology / Virus Screening

Mycoplasma Negative

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46XY - Normal
Passage number: P5
Karyotyping method: KaryoStat Assay

Other Genotyping (Cell Line)